Published 2018
| Version v1
Publication
Targeting CD44/xCT is a potential strategy to sensitize human neuroblastoma stem cells to etoposide
Additional details
- URL
- http://hdl.handle.net/11567/914214
- URN
- urn:oai:iris.unige.it:11567/914214
- Origin repository
- UNIGE